Commercializing Innovation - The Path to the Clinic
Date and Time
October 20, 2016
04:00PM - 05:30PM EDT
Location
Haller Hall, Room 102, Geological Museum, 24 Oxford Street, Cambridge
Speaker: Matthew Shair, Professor of Chemistry & Chemical Biology
Professor Shair studies human disease biology using small molecules and translates these studies towards novel therapeutics. His molecules to treat AML were recently licensed by Merck for clinical development. He has been a founder of several biotech companies including Infinity Pharmaceuticals, Makoto Life Sciences and Chemiderm, and an advisor to several others.
RSVP: Shair.eventbrite.com